Aspergillosis in "nonimmunocompromised" critically ill patients

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 6, 2004, Pages 580-581

  Denning, David W ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; CASPOFUNGIN; CORTICOSTEROID; GALACTOMANNAN; HYDROCORTISONE; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ADRENAL FUNCTION; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTIFICIAL VENTILATION; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BACTERIUM CULTURE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICAL ILLNESS; DISEASE EXACERBATION; DRUG CONTRAINDICATION; EDITORIAL; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS GROWTH; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INSURANCE; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LIVER FAILURE; LUNG ASPERGILLOSIS; MACROPHAGE FUNCTION; NEUTROPENIA; NONHUMAN; PERCUTANEOUS BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEPTIC SHOCK; SEROCONVERSION; UNITED STATES; WATER CONTAMINATION;

ADRENAL CORTEX HORMONES; ASPERGILLOSIS; CRITICAL ILLNESS; HUMANS; IMMUNOCOMPROMISED HOST; LIVER FAILURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 4444221375     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2407004     Document Type: Editorial

References (19)

1. Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 2000;31:1524-1528.
2. Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA. Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-1833.
3. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170:621-625.
4. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003;15:71-75.
5. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003;362:1828-1838.
6. Ng TTC, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiol 1994;140:2475-2480.
7. Aaron SD, Vandemheen KL, Hebert P, Dales R, Stiell IG, Ahuja J, Dickinson G, Brison R, Rowe BH, Dreyer J, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348:2618-2625.
8. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871.
9. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer: an international consensus. Clin Infect Dis 2002;34:7-14.
10. Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA, Glupczynski Y, Installe EJ. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001;27:59-67.
11. Buchheidt D, Baust C, Skladny H, Baldus M, Brauninger S, Hehlmann R. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol 2002;116:803-811.
12. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature and review. Clin Infect Dis 2003;37:S265-S280.
13. Warris A, Voss A, Verweij PE. Hospital sources of Aspergillus: new routes of transmission? Rev Iberoam Micol 2001;18:156-162.
14. Birch M, Nolard N, Shankland G, Denning DW. DNA typing of epidemiologically-related isolates of Aspergillus fumigatus. Infect Epidemiol 1995;114:161-168.
15. Lutz BD, Jin J, Rinaldi MG, Wickes BL, Huycke MM. Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system. Clin Infect Dis 2003;37:786-793.
16. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
17. Denning DW. Therapeutic outcome of invasive aspergillosis. Clin infect Dis 1996;23:608-615.
18. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern W, Marr KA, Ribaud P, Lortholary O, et al. Randomised comparison of voriconazole and amphotericin B in primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
19. Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142-1151.